Which are the causes of Machado-Joseph Disease?

Machado-Joseph Disease, also known as Spinocerebellar Ataxia Type 3 (SCA3), is a progressive neurodegenerative disorder caused by a genetic mutation in the ATXN3 gene located on chromosome 14. This mutation involves an abnormal expansion of a CAG trinucleotide repeat, which leads to the production of a toxic, misfolded protein that damages specific areas of the brain, particularly the cerebellum and brainstem.

What causes Machado-Joseph Disease at the genetic level?

The primary cause of Machado-Joseph Disease is a specific genetic mutation. In healthy individuals, the ATXN3 gene contains a sequence of DNA known as a CAG repeat, typically appearing 12 to 40 times. In individuals with Machado-Joseph Disease, this sequence is abnormally expanded, ranging from 55 to 87 repeats or more. This expansion acts like a "stutter" in the genetic code, causing the cell to manufacture an elongated version of a protein called ataxin-3. Over time, this abnormal protein accumulates and forms clumps (aggregates) within neurons, eventually leading to cell dysfunction and death in the motor and sensory systems.

Is Machado-Joseph Disease hereditary?

Yes, Machado-Joseph Disease is an autosomal dominant disorder. This means that an individual only needs to inherit one copy of the mutated gene from one affected parent to develop the condition. Each child of an affected parent has a 50% chance of inheriting the mutation. A phenomenon known as "anticipation" can also occur, where the CAG repeat size may increase as it is passed down through generations, often leading to an earlier age of onset and potentially more severe symptoms in subsequent generations.

Are there environmental triggers for Machado-Joseph Disease?

Unlike some complex diseases where environmental factors (such as diet, toxins, or infections) play a primary role in disease onset, Machado-Joseph Disease is strictly genetic. There are no known environmental triggers that cause the disease to develop. However, researchers are actively investigating why the clinical presentation and age of onset can vary significantly between people with the exact same number of CAG repeats, suggesting that "modifier genes" or other biological factors may influence how the disease progresses once it has begun.

What is the current state of research into the etiology?

While the genetic cause of Machado-Joseph Disease is well-understood, the exact biological pathway from the production of the mutant ataxin-3 protein to the death of neurons is still a major focus of research. Current studies are exploring several key areas:

• Protein Clearance: Investigating ways to help the body’s cells identify and break down the toxic, misfolded ataxin-3 protein before it clumps together.


• Gene Silencing: Using genetic therapies, such as antisense oligonucleotides (ASOs), to "turn off" or reduce the expression of the mutant ATXN3 gene.


• Mitochondrial Dysfunction: Studying how the mutant protein interferes with the energy-producing centers of the cell (mitochondria), which may contribute to neuronal death.


• Biomarker Discovery: Identifying specific molecules in the blood or spinal fluid that can track the progression of Machado-Joseph Disease, which is essential for testing new treatments in clinical trials.

Next steps

• Consult with a neurologist specializing in movement disorders or ataxia for a formal clinical evaluation.


• Seek a referral to a certified genetic counselor to discuss family planning and the implications of genetic testing.


• Connect with the 42 members of the Machado-Joseph Disease community on DiseaseMaps.org to share experiences and learn about coping strategies.


• Monitor clinical trial registries like ClinicalTrials.gov to stay informed about the latest research and potential therapeutic interventions.

Medical disclaimer: This content is for informational purposes only and does not constitute professional medical advice, diagnosis, or treatment; always seek the advice of your physician or other qualified health provider with any questions regarding a medical condition.

References

• National Institute of Neurological Disorders and Stroke (NINDS) - Spinocerebellar Ataxia Type 3 (Machado-Joseph Disease)


• Orphanet: Spinocerebellar ataxia type 3 (ORPHA:125)


• Online Mendelian Inheritance in Man (OMIM): Spinocerebellar Ataxia 3; SCA3 (#109150)


• National Organization for Rare Disorders (NORD): Machado-Joseph Disease